Pacira BioSciences, Inc. (PCRX) · 10+ Years of Financial Ratios

Profitability	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-67.11	-49.13	-48.13	-46.36	-45.35	-5.53	0.52	-9.72	-8.36	-0.07	-1.45	13.82	2.51	0.85	2.58
Return on Capital (%)	- -	- -	- -	- -	- -	- -	-4.21	- -	- -	- -	- -	- -	10.9	- -	9.82
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	2.76	- -	- -	- -	- -	- -	6.55	- -	3.97
Gross Margin (%)	18.03	15.7	-6.69	17.77	35.98	60.82	71.15	60.16	69.33	74.25	74.65	72.12	74.1	70.11	72.64
EBITDA Margin (%)	-160.71	-124.43	-202.49	-111.68	-55.57	2.46	8.41	-6.91	-2.18	9.09	13.13	14.88	29.8	24.36	24.13
Operating Margin (%)	-190.24	-153.63	-229.98	-126.13	-62.29	-2.61	3.8	-11.59	-7	5.18	8.48	10.15	24.53	10.64	12.94
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	28.48	- -	- -	74.14	21.77	-3,565.82	74.68	-49.41	201.05
Pretax Margin (%)	- -	-186.44	-276.17	-133.77	-75.22	-6.85	0.85	-13.69	-14.82	-0.13	-2.55	4.77	10.42	1.99	9.14
Profit Margin (%)	-211.3	-186.44	-276.17	-133.77	-74.7	-6.94	0.75	-13.73	-14.87	-0.14	-2.62	34.58	7.75	2.39	6.22
Net Income to Common Margin (%)	-211.3	-186.44	-276.17	-133.77	-74.7	-6.94	0.75	-13.73	-14.87	-0.14	-2.62	34.58	7.75	2.39	6.22
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	12.45	- -	- -	- -	- -	- -	25.57	- -	32
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Total Debt	- -	25	28	26	99	103	106	109	276	291	352	541	1,129	763	586
ST Debt	- -	3	8	- -	99	103	106	- -	- -	- -	5	157	383	43	17
LT Debt	- -	22	20	26	- -	- -	- -	109	276	291	347	384	746	721	569
Total Debt/EBITDA	- -	-1.38	-0.89	-0.6	-2.08	21.17	5.06	-5.69	-44.34	9.49	6.37	8.64	6.99	4.7	3.6
Net Debt/EBITDA	0.29	0.06	0.65	0.38	-1.82	-11.31	-2.53	-3.81	-35.66	5.17	4.12	5.79	2.87	3.6	2.27
Total Debt/EBIT	- -	-1.12	-0.79	-0.53	-1.86	-19.96	11.2	-3.4	-13.78	16.64	9.85	12.67	8.5	10.76	6.71
Net Debt/EBIT	0.25	0.05	0.57	0.34	-1.62	10.66	-5.61	-2.27	-11.08	9.06	6.38	8.49	3.49	8.25	4.23
EBITDA to Interest Expense	-6.69	-3.71	-6.65	-24.16	-6.55	0.59	2.71	-2.71	-0.35	1.4	2.34	2.44	5.08	4.06	9.41
EBITDA-CapEx/Interest Expense	-8.22	-5.09	-7.94	-34.26	-8.32	-2.06	-2.63	-6.21	-1.41	0.73	1.91	0.97	3.64	3.31	8.53
EBIT to Interest Expense	-7.92	-4.58	-7.55	-27.28	-7.35	-0.62	1.22	-4.54	-1.11	0.8	1.51	1.66	4.18	1.77	5.04
Interest Expense	4	5	5	2	7	8	8	7	18	22	24	26	32	40	17
Common Equity/Total Assets	-249.72	-205.69	-158.79	-207.48	-174.53	-95.1	-79.12	-88.44	-61.92	-56.31	-48.05	-19.92	-10.21	-8.85	-6.78
Long-Term Debt/Equity (%)	- -	- -	41.59	39.55	- -	- -	- -	49.66	98.82	90.46	97.76	61.98	102.17	92.98	65.35
Long-Term Debt/Capital (%)	- -	-19.55	-13.22	-12.62	- -	- -	- -	-45.79	-245.27	-298.79	-731.45	133.68	81.38	117.23	118.63
Long-Term Debt/Total Assets (%)	- -	32.86	17.69	23.25	- -	- -	- -	27.78	43.95	42.15	41.75	30.13	35.96	42.86	36.12
Total Debt/Equity (%)	- -	-51.78	58.7	39.55	239.91	60.24	48.5	49.66	98.93	90.57	99.15	87.32	154.55	98.5	67.35
Total Debt/Capital (%)	- -	-22.4	-18.65	-12.62	-50.12	-49.8	-52.36	-45.79	-245.56	-299.14	-741.85	188.35	123.1	124.19	122.27
Total Debt/Total Assets (%)	- -	37.64	24.96	23.25	58.27	31.62	27.19	27.78	44	42.2	42.35	42.46	54.39	45.41	37.22
Net Debt to Equity	30.84	2.24	-42.66	-25.09	209.57	-32.18	-24.29	33.24	79.57	49.31	64.18	58.53	63.48	75.53	42.42
Net Debt/Capital (%)	6.06	0.78	10.4	6.64	-41.17	15.08	14.68	-26.62	-133.38	-68.94	-181.29	193.62	139.9	114.65	113.23
EBITDA	-24	-18	-32	-44	-48	5	21	-19	-6	31	55	63	161	162	163
EBITDA-CapEx	-30	-25	-38	-62	-60	-17	-20	-44	-26	16	45	25	116	132	148
Operating Income (Loss)	-29	-22	-36	-49	-53	-5	9	-32	-20	17	36	43	133	71	87

Liquidity	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Cash Ratio	0.49	1.6	2.39	5.19	0.59	1.98	1.72	3.85	5.54	6.32	2.71	2.06	1.26	1.95	2.86
Current Ratio	0.87	1.9	2.59	4.3	0.88	1.53	1.67	5.42	6.96	7.88	3.79	2.57	1.66	3.37	5.24
Quick Ratio	0.59	1.67	2.45	5.5	0.71	2.14	1.89	4.52	6.1	6.95	3.15	2.27	1.44	2.62	3.94
CFO/Avg Current Liab	-1.33	-1.62	-1.29	-3.04	-0.64	0.19	0.2	0.34	0.35	0.84	0.84	0.43	0.32	0.43	1.26
Common Equity/Total Assets	-249.72	-205.69	-158.79	-207.48	-174.53	-95.1	-79.12	-88.44	-61.92	-56.31	-48.05	-19.92	-10.21	-8.85	-6.78
Long-Term Debt/Equity (%)	- -	- -	41.59	39.55	- -	- -	- -	49.66	98.82	90.46	97.76	61.98	102.17	92.98	65.35
Long-Term Debt/Capital (%)	- -	-19.55	-13.22	-12.62	- -	- -	- -	-45.79	-245.27	-298.79	-731.45	133.68	81.38	117.23	118.63
Long-Term Debt/Total Assets (%)	- -	32.86	17.69	23.25	- -	- -	- -	27.78	43.95	42.15	41.75	30.13	35.96	42.86	36.12
Total Debt/Equity (%)	- -	-51.78	58.7	39.55	239.91	60.24	48.5	49.66	98.93	90.57	99.15	87.32	154.55	98.5	67.35
Total Debt/Capital (%)	- -	-22.4	-18.65	-12.62	-50.12	-49.8	-52.36	-45.79	-245.56	-299.14	-741.85	188.35	123.1	124.19	122.27
Total Debt/Total Assets (%)	- -	37.64	24.96	23.25	58.27	31.62	27.19	27.78	44	42.2	42.35	42.46	54.39	45.41	37.22
CFO/Total Liabilities	-31.15	-21.65	-47.53	-151.8	-33.61	16.44	16.93	19.39	5.1	13.28	14.81	11.76	9.35	16.03	21.96
CFO/CapEx	-3.78	-3.68	-5.03	-3.84	-3.38	1.16	0.7	1.35	0.92	3.37	6.94	2.04	2.74	4.83	10.2
Altman's Z-Score	-7.17	-4.05	-0.73	3.47	5.56	12.2	9.8	3.89	3.31	3.43	2.89	2.98	2.05	2.32	2.74

Working Capital	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Accounts Receivable Turnover	7.43	11.01	9.5	12.09	9.03	10.7	10.33	9.91	9.31	9.68	9.85	8.37	7.25	6.85	6.62
Days Sales Outstanding	49.13	33.16	38.43	30.19	40.41	34.12	35.34	36.84	39.22	37.69	37.07	43.62	50.34	53.29	55.14
Inventory Turnover	6.55	7.36	11.75	4.82	3.96	3.46	1.58	2.37	2.42	1.93	2	1.91	1.72	2.05	1.84
Days Inventory Outstanding	55.74	49.56	31.07	75.65	92.08	105.63	230.95	154.02	150.89	189.09	182.76	191.24	212.36	178.21	198.06
Accounts Payable Turnover	1.28	1.86	3.46	14.3	20.66	18.55	13.45	9.81	8.85	6.48	8.57	10.65	16.61	15.28	12.48
Accounts Payable Turnover Days	285.69	195.72	105.61	25.52	17.66	19.68	27.14	37.19	41.26	56.35	42.58	34.28	21.98	23.89	29.24
Cash Conversion Cycle	-180.81	-112.99	-36.1	80.32	114.82	120.07	239.16	153.67	148.85	170.43	177.26	200.58	240.71	207.61	223.96
Inventory to Cash Days	-6.61	-16.4	7.36	-45.46	-51.67	-71.51	-195.61	-117.18	-111.67	-151.4	-145.69	-147.62	-162.02	-124.92	-142.92
Inventories	2	2	1	12	16	29	62	31	41	49	58	65	99	96	104
Raw Materials	1	1	1	4	5	9	17	12	16	19	20	27	36	40	54
Work In Process	- -	- -	- -	6	6	9	12	12	8	10	14	16	35	29	31
Finished Goods	1	- -	- -	2	4	11	33	8	17	20	24	21	27	27	19
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Market Capitalization	- -	- -	217	570	1,900	3,290	2,821	1,183	1,848	1,761	1,865	2,558	2,723	1,784	1,557
- Cash & Cash Equivalents	7	26	46	43	13	158	159	36	54	133	78	100	586	104	153
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	25	28	26	99	103	106	109	276	291	352	541	1,129	763	586
Enterprise Value	-7	-1	169	522	1,927	3,116	2,666	1,119	1,814	1,669	1,925	2,578	3,196	2,259	1,865
Total Capital	-110	-112	-152	-206	-197	-207	-202	-237	-113	-97	-47	287	917	615	479
Total Debt/Capital (%)	- -	-22.4	-18.65	-12.62	-50.12	-49.8	-52.36	-45.79	-245.56	-299.14	-741.85	188.35	123.1	124.19	122.27
Total Debt / EV	- -	-23.28	0.17	0.05	0.05	0.03	0.04	0.1	0.15	0.17	0.18	0.21	0.35	0.34	0.31
EV/Sales	- -	- -	10.79	13.37	22.52	15.77	10.71	4.05	6.33	4.95	4.57	6.13	5.9	3.39	2.76
EV/EBITDA	- -	- -	- -	- -	- -	639.89	127.38	- -	- -	54.46	34.82	41.18	19.8	13.91	11.45
EV/EBIT	- -	- -	- -	- -	- -	- -	281.97	- -	- -	95.48	53.91	60.37	24.06	31.85	21.35
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	92.05	74.56	27.6	50.53	22.8	20.32	9.8	21.4	11.7	11.2
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	55.91	34.61	17.15	32.88	19.03	18.35	8.57	16.37	10.12	10.27
Diluted Market Cap	- -	- -	141	530	1,874	3,213	3,162	1,175	1,809	1,748	1,848	2,561	2,778	1,808	1,741
Diluted Enterprise Value	-7	-1	123	513	1,961	3,158	3,109	1,248	2,032	1,907	2,121	3,002	3,321	2,467	2,174
EV per Share	- -	- -	6.68	16.02	57.28	86.2	72.35	29.85	44.59	40.49	45.94	59.08	71.44	49.19	40.11
TTM Sales	15	15	16	39	86	198	249	276	287	337	421	421	542	667	675
TTM EBITDA	-24	-18	-32	-44	-48	5	21	-19	-6	31	55	63	161	162	163
TTM Operating Income	-29	-22	-36	-49	-53	-5	9	-32	-20	17	36	43	133	71	87
TTM Cash Flow to Firm	- -	-20	-26	-68	-36	34	36	41	36	73	95	263	149	193	166
TTM Free Cash Flow to Firm	- -	-13	-20	-50	-23	56	77	65	55	88	105	301	195	223	182

Multiples	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Price/Earnings	- -	- -	- -	- -	- -	- -	1,507.28	- -	- -	- -	- -	17.19	64.19	111.16	36.91
Price/Earnings Average	- -	- -	-3.51	-7.98	-18.24	-216.63	1,460.02	-44.23	-39.59	-3,475.78	-154.56	14.69	65.16	169.02	40.33
Price/Earnings High	- -	- -	-5.35	-10.84	-29.16	-275.83	2,283.95	-72.27	-47.41	-4,371.66	-174.93	19.15	80.8	230.37	51.22
Price/Earnings Low	- -	- -	-2.36	-4.61	-9.02	-143.68	720.96	-29.68	-29.75	-2,388.65	-134.38	8.33	50.58	109.27	29
Price/Book Value	- -	- -	-1.2	-2.45	-6.41	-10.61	-9.15	-3.42	-4.75	-4.54	-4.67	-10.08	-12.86	-12	-14.59
Price/Book Value Average	- -	- -	-1.3	-1.93	-3.99	-9.81	-8.86	-4.88	-4.43	-4.25	-4.3	-8.62	-13.05	-18.24	-15.94
Price/Book Value High	- -	- -	-1.98	-2.62	-6.37	-12.49	-13.87	-7.97	-5.3	-5.34	-4.87	-11.23	-16.18	-24.87	-20.24
Price/Book Value Low	- -	- -	-0.88	-1.12	-1.97	-6.51	-4.38	-3.27	-3.33	-2.92	-3.74	-4.88	-10.13	-11.8	-11.46
Price/Tangible Book Value	- -	- -	5.05	10.59	63.83	22.39	15.05	6.87	8.24	6.8	12.35	6.04	-70.31	25.05	6.96
Price/Tangible Book Value Average	- -	- -	5.45	8.33	39.69	20.7	14.58	9.81	7.69	6.36	11.38	5.16	-71.37	38.09	7.61
Price/Tangible Book Value High	- -	- -	8.31	11.32	63.48	26.36	22.81	16.03	9.2	8	12.88	6.73	-88.5	51.92	9.66
Price/Tangible Book Value Low	- -	- -	3.67	4.82	19.64	13.73	7.2	6.58	5.78	4.37	9.9	2.93	-55.4	24.63	5.47
Price/Sales	- -	- -	8.98	13.56	21.91	16.25	11.24	4.25	6.31	5.18	4.39	5.94	4.98	2.65	2.29
Price/Sales Average	- -	- -	9.69	10.68	13.62	15.03	10.88	6.07	5.89	4.85	4.04	5.08	5.05	4.03	2.51
Price/Sales High	- -	- -	14.78	14.5	21.79	19.14	17.02	9.92	7.05	6.1	4.58	6.62	6.26	5.5	3.18
Price/Sales Low	- -	- -	6.53	6.17	6.74	9.97	5.37	4.08	4.42	3.34	3.52	2.88	3.92	2.61	1.8
Price/Cash Flow	- -	- -	-4.54	-7.56	-43.37	126.15	96.48	35.12	101.73	35.77	26.2	32.48	21.43	12.17	10.01
Price/Cash Flow Average	- -	- -	-4.9	-5.95	-26.97	116.66	93.45	50.17	94.86	33.5	24.14	27.76	21.76	18.51	10.94
Price/Cash Flow High	- -	- -	-7.48	-8.08	-43.13	148.55	146.19	81.98	113.59	42.13	27.33	36.17	26.98	25.23	13.9
Price/Cash Flow Low	- -	- -	-3.3	-3.44	-13.34	77.38	46.15	33.67	71.29	23.02	20.99	15.73	16.89	11.97	7.87
Price/Free Cash Flow	- -	- -	-5.67	-10.22	-61.6	67.84	45	20.2	48.83	27.58	22.9	22.3	16.19	10.31	10.25
Price/Free Cash Flow Average	- -	- -	-6.12	-8.04	-38.31	62.74	43.59	28.86	45.53	25.83	21.1	19.06	16.43	15.68	11.21
Price/Free Cash Flow High	- -	- -	-9.34	-10.92	-61.27	79.89	68.19	47.15	54.52	32.49	23.89	24.84	20.38	21.37	14.23
Price/Free Cash Flow Low	- -	- -	-4.12	-4.65	-18.96	41.61	21.52	19.37	34.22	17.75	18.35	10.8	12.76	10.14	8.06
EV/Sales	- -	- -	10.79	13.37	22.52	15.77	10.71	4.05	6.33	4.95	4.57	6.13	5.9	3.39	2.76
EV/Sales Average	- -	- -	13.8	11.06	14.82	15.12	10.76	6.38	6.79	5.36	4.73	6.24	6.11	5.06	3.16
EV/Sales High	- -	- -	21.65	15.17	23.09	19.32	16.95	10.25	7.98	6.62	5.27	7.82	7.33	6.53	3.84
EV/Sales Low	- -	- -	8.93	6.21	7.84	9.93	5.21	4.37	5.29	3.83	4.2	3.99	4.97	3.62	2.45
EV/EBITDA	- -	- -	- -	- -	- -	639.89	127.38	- -	- -	54.46	34.82	41.18	19.8	13.91	11.45
EV/EBITDA Average	0.29	0.06	-6.82	-9.9	-26.67	613.53	128.03	-92.24	-312.06	59	36.04	41.98	20.5	20.76	13.1
EV/EBITDA High	0.29	0.06	-10.69	-13.58	-41.56	784.31	201.71	-148.3	-366.63	72.87	40.14	52.56	24.61	26.82	15.92
EV/EBITDA Low	0.29	0.06	-4.41	-5.56	-14.11	403.13	61.94	-63.16	-243.37	42.16	31.98	26.84	16.66	14.86	10.17
EV/EBIT	- -	- -	- -	- -	- -	- -	281.97	- -	- -	95.48	53.91	60.37	24.06	31.85	21.35
EV/EBIT Average	0.25	0.05	-6	-8.77	-23.79	-578.49	283.41	-55.03	-96.97	103.44	55.8	61.55	24.9	47.55	24.44
EV/EBIT High	0.25	0.05	-9.41	-12.03	-37.08	-739.52	446.5	-88.47	-113.92	127.76	62.14	77.07	29.9	61.43	29.7
EV/EBIT Low	0.25	0.05	-3.88	-4.93	-12.59	-380.11	137.11	-37.68	-75.62	73.92	49.51	39.36	20.24	34.02	18.97
Last Price	- -	- -	8.57	17.47	56.48	91.02	76.56	31.55	45.45	42.73	44.51	58.63	60.88	38.85	33.5
High Price	- -	- -	14.11	18.68	56.17	107.18	116.01	73.65	50.75	50.33	46.42	65.3	76.63	80.51	46.49
Low Price	- -	- -	6.23	7.95	17.38	55.83	36.62	30.25	31.85	27.5	35.66	28.4	47.97	38.19	26.32
Enterprise Value	-7	-1	169	522	1,927	3,116	2,666	1,119	1,814	1,669	1,925	2,578	3,196	2,259	1,865
Enterprise Value Average	-7	-1	217	432	1,268	2,988	2,680	1,762	1,946	1,808	1,993	2,628	3,308	3,372	2,134
Enterprise Value High	-7	-1	340	593	1,976	3,820	4,222	2,833	2,286	2,233	2,219	3,291	3,971	4,357	2,594
Enterprise Value Low	-7	-1	140	243	671	1,963	1,296	1,207	1,518	1,292	1,768	1,680	2,689	2,413	1,656

Per Share Data Items	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Shares Outstanding	1	17	25	33	34	36	37	37	41	41	42	44	45	46	46
Diluted Weighted Avg Shares	1	17	16	30	33	35	41	37	40	41	42	44	46	47	52
Basic Weighted Avg Shares	1	17	16	30	33	35	37	37	40	41	42	43	44	46	46
Revenue per Share	26.19	0.85	0.95	1.29	2.58	5.6	6.81	7.42	7.2	8.24	10.14	9.86	12.23	14.65	14.6
EBITDA per Share	-42.09	-1.05	-1.93	-1.44	-1.43	0.14	0.57	-0.51	-0.16	0.75	1.33	1.47	3.65	3.57	3.52
Operating Income per Share	-49.82	-1.3	-2.2	-1.63	-1.61	-0.15	0.26	-0.86	-0.5	0.43	0.86	1	3	1.56	1.89
Basic EPS, GAAP	-55.34	-1.58	-2.64	-1.72	-1.93	-0.39	0.05	-1.02	-1.07	-0.01	-0.27	3.41	0.95	0.35	0.91
Basic EPS from Cont Ops	-55.34	-1.58	-2.64	-1.72	-1.93	-0.39	0.05	-1.02	-1.07	-0.01	-0.27	3.41	0.95	0.35	0.91
Diluted EPS, GAAP	-55.34	-1.58	-2.64	-1.72	-1.93	-0.39	0.04	-1.02	-1.07	-0.01	-0.27	3.33	0.92	0.34	0.81
Diluted EPS from Cont Ops	-55.34	-1.58	-2.64	-1.72	-1.93	-0.39	0.04	-1.02	-1.07	-0.01	-0.27	3.33	0.92	0.34	0.81
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-36.37	-1.44	-1.89	-2.31	-1.3	0.72	0.79	0.9	0.45	1.19	1.7	1.81	2.84	3.19	3.35
Free Cash Flow per Basic Share	-45.98	-1.84	-2.26	-2.91	-1.69	0.1	-0.34	0.23	-0.04	0.84	1.45	0.92	1.8	2.53	3.02
Cash & Equivalents per Share	12.35	1.52	3.01	2.25	2.15	7.67	7.08	4.6	7.66	9.3	6.97	11.95	14.67	6.28	5.99
Book Value per Share	-191.55	-7.94	-7.11	-7.13	-8.81	-8.58	-8.37	-9.24	-9.57	-9.42	-9.53	-5.82	-4.74	-3.24	-2.3
Tangible Book Value per Share	-59.57	-3.33	1.7	1.65	0.88	4.07	5.09	4.6	5.51	6.29	3.6	9.71	-0.87	1.55	4.81

Pacira BioSciences, Inc.

PCRX US

28.37

28.37